{"entity":{"type":"insider","cik":"0001586893","url":"/insider/0001586893","json_url":"/insider/0001586893.json","name":"Wolchko J Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":83,"n_filings":26,"first":"2014-04-02","last":"2024-01-10","span_basis":"filed_date"},"name_variants":[{"name":"Wolchko J Scott","source":"filing","n_filings":26,"first_seen":"2014-04-02","last_seen":"2024-01-10"}],"transactions":[{"id":2175121,"accession":"0000950170-24-003648","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-003648","line_url":"/filing/0000950170-24-003648#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14391.0,"shares_display":"14,391","price_per_share":4.37,"price_display":"4.37","price_state":"stated","total_value":62888.67,"total_display":"62,888.67","total_whole":"62,889","shares_owned_after":371248.0,"shares_owned_after_display":"371,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-10","scope":"insider"},{"id":8492878,"accession":"0001209191-23-002979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002979","line_url":"/filing/0001209191-23-002979#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45907.0,"shares_display":"45,907","price_per_share":5.24,"price_display":"5.24","price_state":"stated","total_value":240552.68,"total_display":"240,552.68","total_whole":"240,553","shares_owned_after":385639.0,"shares_owned_after_display":"385,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-11","scope":"insider"},{"id":6185301,"accession":"0001209191-22-043143","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-22-043143","line_url":"/filing/0001209191-22-043143","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6246.0,"shares_display":"6,246","price_per_share":32.07749279538905,"price_display":"32.08","price_state":"stated","total_value":200356.02,"total_display":"200,356.02","total_whole":"200,356","shares_owned_after":434869.0,"shares_owned_after_display":"434,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-22","filed_date":"2022-07-25","scope":"insider","n_lines":3},{"id":6185287,"accession":"0001209191-22-043143","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-043143","line_url":"/filing/0001209191-22-043143","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":32.878687666666664,"price_display":"32.88","price_state":"stated","total_value":986360.63,"total_display":"986,360.63","total_whole":"986,361","shares_owned_after":431546.0,"shares_owned_after_display":"431,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-21","filed_date":"2022-07-25","scope":"insider","n_lines":2},{"id":6295988,"accession":"0001209191-22-025515","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-22-025515","line_url":"/filing/0001209191-22-025515","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":34.591118,"price_display":"34.59","price_state":"stated","total_value":345911.18,"total_display":"345,911.18","total_whole":"345,911","shares_owned_after":432384.0,"shares_owned_after_display":"432,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-22","filed_date":"2022-04-25","scope":"insider","n_lines":2},{"id":6295981,"accession":"0001209191-22-025515","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-025515","line_url":"/filing/0001209191-22-025515","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":34.996017,"price_display":"35.00","price_state":"stated","total_value":1049880.51,"total_display":"1,049,880.51","total_whole":"1,049,881","shares_owned_after":438831.0,"shares_owned_after_display":"438,831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-21","filed_date":"2022-04-25","scope":"insider","n_lines":4},{"id":6388088,"accession":"0001209191-22-004606","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-004606","line_url":"/filing/0001209191-22-004606#line-4","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":38.02,"price_display":"38.02","price_state":"stated","total_value":380200.0,"total_display":"380,200.00","total_whole":"380,200","shares_owned_after":431546.0,"shares_owned_after_display":"431,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-21","filed_date":"2022-01-24","scope":"insider"},{"id":6388080,"accession":"0001209191-22-004606","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-004606","line_url":"/filing/0001209191-22-004606#line-2","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":40.21,"price_display":"40.21","price_state":"stated","total_value":1206300.0,"total_display":"1,206,300.00","total_whole":"1,206,300","shares_owned_after":431546.0,"shares_owned_after_display":"431,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-20","filed_date":"2022-01-24","scope":"insider"},{"id":6749603,"accession":"0001209191-22-003174","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-003174","line_url":"/filing/0001209191-22-003174","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14566.0,"shares_display":"14,566","price_per_share":48.67683852807909,"price_display":"48.68","price_state":"stated","total_value":709026.83,"total_display":"709,026.83","total_whole":"709,027","shares_owned_after":436065.0,"shares_owned_after_display":"436,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-01-13","scope":"insider","n_lines":2},{"id":6776463,"accession":"0001209191-22-003054","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-003054","line_url":"/filing/0001209191-22-003054","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34156.0,"shares_display":"34,156","price_per_share":46.85951692235625,"price_display":"46.86","price_state":"stated","total_value":1600533.66,"total_display":"1,600,533.66","total_whole":"1,600,534","shares_owned_after":446213.0,"shares_owned_after_display":"446,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-10","filed_date":"2022-01-12","scope":"insider","n_lines":3},{"id":4904118,"accession":"0001209191-21-066168","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-066168","line_url":"/filing/0001209191-21-066168#line-2","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":54.27,"price_display":"54.27","price_state":"stated","total_value":1085400.0,"total_display":"1,085,400.00","total_whole":"1,085,400","shares_owned_after":393793.0,"shares_owned_after_display":"393,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-22","scope":"insider"},{"id":4287540,"accession":"0001209191-21-061485","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-061485","line_url":"/filing/0001209191-21-061485#line-7","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":58.88,"price_display":"58.88","price_state":"stated","total_value":1766400.0,"total_display":"1,766,400.00","total_whole":"1,766,400","shares_owned_after":393793.0,"shares_owned_after_display":"393,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-22","filed_date":"2021-10-25","scope":"insider"},{"id":4287526,"accession":"0001209191-21-061485","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-061485","line_url":"/filing/0001209191-21-061485","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":60.218655,"price_display":"60.22","price_state":"stated","total_value":1806559.65,"total_display":"1,806,559.65","total_whole":"1,806,560","shares_owned_after":408558.0,"shares_owned_after_display":"408,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-21","filed_date":"2021-10-25","scope":"insider","n_lines":2},{"id":5252560,"accession":"0001209191-21-052744","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-052744","line_url":"/filing/0001209191-21-052744#line-2","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":88.0102,"price_display":"88.01","price_state":"stated","total_value":1760204.0,"total_display":"1,760,204.00","total_whole":"1,760,204","shares_owned_after":393793.0,"shares_owned_after_display":"393,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-19","filed_date":"2021-08-20","scope":"insider"},{"id":4204882,"accession":"0000899243-21-029868","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-21-029868","line_url":"/filing/0000899243-21-029868#line-7","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":85.2846,"price_display":"85.28","price_state":"stated","total_value":2558538.0,"total_display":"2,558,538.00","total_whole":"2,558,538","shares_owned_after":393793.0,"shares_owned_after_display":"393,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-23","filed_date":"2021-07-26","scope":"insider"},{"id":4204869,"accession":"0000899243-21-029868","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-029868","line_url":"/filing/0000899243-21-029868","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":86.05251269666667,"price_display":"86.05","price_state":"stated","total_value":2581575.3809,"total_display":"2,581,575.38","total_whole":"2,581,575","shares_owned_after":395393.0,"shares_owned_after_display":"395,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-22","filed_date":"2021-07-26","scope":"insider","n_lines":3},{"id":4273703,"accession":"0001209191-21-035301","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-035301","line_url":"/filing/0001209191-21-035301#line-2","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":77.1646,"price_display":"77.16","price_state":"stated","total_value":1543292.0,"total_display":"1,543,292.00","total_whole":"1,543,292","shares_owned_after":393793.0,"shares_owned_after_display":"393,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-20","filed_date":"2021-05-24","scope":"insider"},{"id":5332539,"accession":"0001209191-21-028259","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-028259","line_url":"/filing/0001209191-21-028259#line-6","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":85.2428,"price_display":"85.24","price_state":"stated","total_value":2557284.0,"total_display":"2,557,284.00","total_whole":"2,557,284","shares_owned_after":393793.0,"shares_owned_after_display":"393,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-23","filed_date":"2021-04-26","scope":"insider"},{"id":5332524,"accession":"0001209191-21-028259","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-028259","line_url":"/filing/0001209191-21-028259#line-2","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":85.5404,"price_display":"85.54","price_state":"stated","total_value":2566212.0,"total_display":"2,566,212.00","total_whole":"2,566,212","shares_owned_after":393793.0,"shares_owned_after_display":"393,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-22","filed_date":"2021-04-26","scope":"insider"},{"id":4474759,"accession":"0001209191-21-012326","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-012326","line_url":"/filing/0001209191-21-012326","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":102.012910915,"price_display":"102.01","price_state":"stated","total_value":2040258.2183,"total_display":"2,040,258.22","total_whole":"2,040,258","shares_owned_after":399340.0,"shares_owned_after_display":"399,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-18","filed_date":"2021-02-19","scope":"insider","n_lines":5},{"id":5189619,"accession":"0001209191-21-004957","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-21-004957","line_url":"/filing/0001209191-21-004957","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":98.28704951,"price_display":"98.29","price_state":"stated","total_value":2948611.4853,"total_display":"2,948,611.49","total_whole":"2,948,611","shares_owned_after":411026.0,"shares_owned_after_display":"411,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-22","filed_date":"2021-01-22","scope":"insider","n_lines":4},{"id":5189590,"accession":"0001209191-21-004957","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-21-004957","line_url":"/filing/0001209191-21-004957","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":103.04522718,"price_display":"103.05","price_state":"stated","total_value":3091356.8154,"total_display":"3,091,356.82","total_whole":"3,091,357","shares_owned_after":398909.0,"shares_owned_after_display":"398,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-21","filed_date":"2021-01-22","scope":"insider","n_lines":8},{"id":4772462,"accession":"0001209191-21-003341","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-003341","line_url":"/filing/0001209191-21-003341#line-7","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586893","owner_name":"Wolchko J Scott","owner_display_name":"Wolchko J Scott","owner_url":"/insider/0001586893","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3515.0,"shares_display":"3,515","price_per_share":111.616,"price_display":"111.62","price_state":"stated","total_value":392330.24,"total_display":"392,330.24","total_whole":"392,330","shares_owned_after":355634.0,"shares_owned_after_display":"355,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-12","scope":"insider"}],"collapsed":true,"next_cursor":"2021-01-11|4772462","ledger_fault":false,"count":{"value":83,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":83,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":83},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434316","name":"FATE THERAPEUTICS INC","url":"/issuer/0001434316","role":"Director, Officer (President and CEO)","n_filings":26,"first_seen":"2014-04-02","last_seen":"2024-01-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001586893","retrieved_at":"2026-08-27T14:50:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}